News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article provides a technical analysis of Molecular Partners AG (MOLN), detailing its current stock price momentum, support and resistance levels, and indicator readings. It shows that MOLN has a price momentum score of 2.98, trading between resistance at $4.10 and support at $3.64, …
Sharemaestro market context Price below Trend Line 52 weeks +14.7%4D Molecular Therapeutics Inc (FDMT) has a stable financial status with a financial score of 7.34, ranking 132nd in its industry. The company reported a significant year-over-year revenue increase of 21664.29% to $3.05M and a net profit increase of 43.33%. However, its operational efficiency …
Colgate-Palmolive Co. (CL) has an estimated 33,729 employees worldwide as of March 2026, marking a 1.0% increase from 2023. The company is actively hiring, with 1,045 active job postings in 2026, a 42.9% rise from 2025. Its workforce is primarily located in the United …
Colgate-Palmolive (India) Ltd substantially increased its advertising and promotional spending by 33.6% to Rs 251.8 crore in Q1 FY27, which contributed to a 12% revenue growth and 6.8% profit increase. CEO Prabha Narasimhan emphasized continued investment in brand building, product innovation, and category premiumisation …
Colgate-Palmolive India reported a 6.9% rise in quarterly net profit to 3.43 billion rupees, driven by strong demand in its oral care segment and premium products. The company's sales increased by 12% to 15.91 billion rupees, exceeding analyst estimates. Despite commodity inflation, the company …
Colgate-Palmolive (India) reported a Q1 net profit of 3.43 billion Rupees. The article, sourced from Reuters, provides this key financial update for the company.
Colgate-Palmolive (India) has successfully met its 2025 Sustainability & Social Impact Strategy goals and introduced its new 2030 SMILE Strategy, continuing its 'We Make India Smile' initiative. The company outlined ambitious new targets for climate action, circularity, oral care access, and community impact, building …
Colgate-Palmolive Company (EUROTLX:4CL) generated 17.35 billion EUR in revenue last year. The Oral, Personal and Home Care segment was the top performer, contributing 13.43 billion EUR. The United States was the largest regional contributor, accounting for 5.67 billion EUR.
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) generated $85.21 million USD in revenue last year, primarily from its Disease-targeted Therapeutics segment. The company's largest contribution by country came from Japan, accounting for $85.00 million USD. This represents a significant increase from the previous year's revenue …
Colgate-Palmolive (India) has successfully met its 2025 sustainability targets, including a 43% reduction in carbon emissions and a transition to 100% recyclable toothpaste tubes. The company has now launched its 2030 SMILE Strategy, aiming for net-zero emissions by 2040, a 33% reduction in virgin …
SummitTX Capital L.P. recently acquired a new stake in Colgate-Palmolive Company (NYSE:CL) totaling 76,563 shares, valued at approximately $6.53 million, during the first quarter. This investment is part of a broader trend of institutional investors modifying their holdings in Colgate-Palmolive. Analysts currently rate Colgate-Palmolive …
This article provides a comprehensive overview of Molecular Partners AG (MOLN), including its current stock performance, key financial figures, and analyst ratings. The company, a Switzerland-based clinical-stage biotech firm, is developing DARPin therapeutics and is considered fairly valued with strong fundamentals. While analysts rate …
Molson Coors Beverage Company Class B (TAP) is showing mixed sentiment and choppy conditions across different time horizons, with support being tested. AI models have generated three trading strategies (Position, Momentum Breakout, Risk Hedging) tailored to various risk profiles, each with specific entry, target, …
Molina Healthcare Inc (MOH) shows relatively healthy fundamentals and significant growth potential, although its valuation is considered fairly valued within the Healthcare Providers & Services industry. Analysts rate it a "Hold" with a target price indicating upside, despite recent weak stock market performance. The …
This article provides a valuation analysis of Moleculin Biotech Inc (MBRX), noting its current valuation score of 7.38, ranking 230 out of 386 in the Biotechnology & Medical Research industry. It highlights the company's current P/E ratio of -0.14 and mentions that relevant data …
This article provides the quarterly and annual income statements for 4D Molecular Therapeutics Inc (FDMT), detailing key financial metrics such as total revenue, operating expenses, operating profit, and net income. It also includes an FAQ section explaining how to read the income statement, the …
This article provides access to the revenue breakdown for Moleculin Biotech, Inc. (NASDAQ: MBRX) on TradingView. It highlights the availability of financial data, segments, and regional performance details for the pharmaceutical company. The content primarily serves as a gateway to Moleculin Biotech's financial information …
Lazard Asset Management LLC significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 14.2% in the first quarter, now holding over 2 million shares valued at $172.03 million. Other institutional investors also adjusted their positions, with Colgate-Palmolive showing strong financial performance, a dividend announcement, …
OMERS Administration Corp. drastically reduced its stake in Colgate-Palmolive Company by 96.6% in the first quarter, selling over 1.6 million shares but still retaining shares valued at $4.93 million. Despite this, institutional investors collectively hold a substantial 80.41% of the company, and analysts maintain …
This article provides a detailed cash flow statement for 4D Molecular Therapeutics Inc (FDMT), covering quarterly and annual data for operating, investing, and financing activities. It presents key financial figures including operating cash flow, net income, capital expenditures, and free cash flow over several …
This article provides historical dividend and stock split information for 4D Molecular Therapeutics Inc (FDMT). It states that the company has not distributed any dividends over the past five years. The page also shows FDMT's current stock price, market cap, and other financial overview …
Bank of Nova Scotia significantly reduced its stake in Colgate-Palmolive Company (NYSE:CL) by selling 372,628 shares, decreasing its holdings by 76.5% during the first quarter. This move resulted in the fund owning 114,437 shares valued at $9.75 million. Other institutional investors, however, showed varied …
Earlier this month, Molson Coors Beverage's Board declared a regular quarterly dividend of US$0.48 per share on its Class A and Class B common stock, payable on September 18, 2026, to shareholders of record as of August 28, 2026. This dividend affirmation comes as …
Cricket icon Rahul Dravid inaugurated the Colgate Total Inter-College 5-A-Side Hockey Tournament at St. Joseph's College of Commerce, celebrating the institution's Bachelor of Commerce program's platinum jubilee. The tournament, organized by SJCC Alumni Association and YES for HOCKEY, aimed to highlight the importance of …
JP Morgan has increased its target price for Molina Healthcare Inc. (MOH.N) to $220, up from the previous $191. This update reflects the analyst's revised outlook on the healthcare company's valuation. The article, sourced from Reuters, reports only this target price adjustment without further …
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (MOH) on behalf of investors who purchased securities prior to February 5, 2025, and still hold them. The investigation focuses on whether Molina or its officers and directors engaged in corporate …
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. The latest move from Molson Coors Beverage (TAP) is a Board decision to declare a regular quarterly dividend of $0.48 per share, providing a key …
This article details the shareholder structure of Molecular Partners AG (MOLN), listing major shareholders such as Suvretta Capital Management, LLC and BVF Partners L.P., and categorizing shareholder types. It also provides institutional shareholding data over several quarters and recent shareholder activity with specific changes …
Search by ticker symbol or company name and select a result to open its chart. The US only control limits results to active US-listed stocks and ETFs.
Showing active US-listed stocks and ETFs only.